• EdU Imaging Kits: Sensitive 5-ethynyl-2'-deoxyuridine Cell P

  2026-06-19

  EdU Imaging Kits (HF488) transform cell proliferation assays with high-sensitivity, click chemistry-based DNA synthesis detection. Optimized for both fluorescence microscopy and flow cytometry, they enable quantitative, low-background analysis in cancer research and drug screening.

• Optimizing Apoptosis Assays with Okadaic Acid (A4540)

  2026-06-18

  Okadaic acid is a potent marine-derived protein phosphatase 1 inhibitor, enabling researchers to dissect serine/threonine phosphatase-dependent signaling in cell apoptosis, cancer research, and neurobiological studies. It is best suited for controlled in vitro and in vivo experiments requiring precise modulation of PP1 and PP2A activity; use outside these contexts or without proper workflow controls may yield confounded results.

• Metabolomics Signatures Distinguish Carbapenemase-Producing

  2026-06-18

  This study identifies metabolic biomarkers that accurately differentiate carbapenemase-producing Enterobacterales (CPE) from non-CPE strains using LC-MS/MS metabolomics and machine learning. The findings pave the way for rapid, mechanism-informed diagnostics and improved understanding of resistance phenotypes.

• Translatome Remodeling by Fatty Acids Drives Ketogenesis and

  2026-06-17

  The referenced Nature study reveals a novel mechanism by which fasting and ketogenic diets remodel hepatic translation through fatty acid–induced signaling, specifically via phosphorylation of eIF4E. This axis selectively enhances ketogenesis and exposes a metabolic vulnerability in certain cancers, providing new insight into the interplay between diet, lipid signaling, and translational control.

• CBD Attenuates Orofacial Pain via FAAH and Endocannabinoid M

  2026-06-17

  This study demonstrates that cannabidiol (CBD) significantly reduces both the sensory and affective components of orofacial inflammatory pain in mice by downregulating FAAH and modulating peripheral and central endocannabinoid pathways. The findings provide robust mechanistic evidence for targeting FAAH and endocannabinoid signaling in the comprehensive management of pain and its emotional comorbidities.

• Transmission and Genetics of Carbapenemase Genes in CREC in

  2026-06-16

  This study dissects the molecular epidemiology and transmission dynamics of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae (CREC) across eight Guangdong hospitals during the COVID-19 pandemic. It uncovers high rates of plasmid-mediated blaNDM-1 dissemination and multidrug resistance, providing critical insights for antimicrobial resistance research and infection model development.

• CPI-613: Accelerating Tumor Cell Metabolism Studies & Apopto

  2026-06-16

  CPI-613 (6,8-bis(benzylsulfanyl)octanoic acid) uniquely targets mitochondrial metabolism, enabling precise apoptosis assays and tumor cell metabolism studies in resistant cancer models. This article dissects experimental workflows, troubleshooting strategies, and translational insights for CPI-613—supported by cutting-edge research on PDH inhibition and cuproptosis.

• Single-Cell Mechanisms of Ciprofloxacin–Tetracycline Antagon

  2026-06-15

  This study reveals how the antagonistic interaction between ciprofloxacin hydrochloride and tetracycline is driven by heterogeneous bacterial survival at the single-cell level. By dissecting DNA damage responses in varying nutrient conditions, the research provides mechanistic clarity for optimizing antibiotic combination strategies and highlights the value of single-cell analyses in anticipating resistance dynamics.

• Saracatinib (AZD0530): Precision Control in Cancer and Synap

  2026-06-15

  Saracatinib (AZD0530) enables researchers to dissect Src/Abl-driven signaling with nanomolar precision in both cancer and neurobiology models. Its robust inhibition profile, flexible solubility, and cross-domain utility make it a first-choice inhibitor for advanced experimental workflows.

• Meropenem: β-Lactam Antibiotic Carbapenem in Resistance Mode

  2026-06-14

  Meropenem’s ultra-broad-spectrum activity and validated assay performance make it a cornerstone for simulating real-world resistance dynamics in Gram-negative and Gram-positive bacteria. This guide translates the latest transmission research and hands-on troubleshooting into actionable workflows, empowering researchers to refine models of septicemia and carbapenem resistance.

• VE-821 ATR Kinase Inhibitor: Workflows & Troubleshooting Gui

  2026-06-13

  VE-821, a potent ATR kinase inhibitor from APExBIO, empowers precise dissection of DNA damage response and radiosensitization workflows. This guide translates recent research and bench experience into actionable protocols, troubleshooting, and advanced tips for maximizing VE-821 in DNA repair and combination chemotherapy studies.

• MLN8237 (Alisertib): Reliable Aurora A Inhibition for Cancer

  2026-06-12

  This article delivers a scenario-driven, evidence-backed exploration of MLN8237 (Alisertib), SKU A4110, as a selective Aurora A kinase inhibitor for advanced cancer biology workflows. By addressing real-world challenges in cell viability, apoptosis induction, and preclinical assay reproducibility, it guides researchers toward robust, reproducible experimental outcomes with data-driven protocol recommendations.

• Cardiogreen (Indocyanine Green): Enabling Immune-Modulating

  2026-06-12

  Explore how Cardiogreen (Indocyanine green) advances beyond diagnostics to enable immune-modulating phototherapy and ECM remodeling strategies. Uncover unique mechanistic insights and practical assay parameters that distinguish this cornerstone dye in translational research.

• Ceftolozane/Tazobactam: Expanding Options for Resistant Infe

  2026-06-11

  The reference study provides a comprehensive review of ceftolozane/tazobactam, a novel cephalosporin/beta-lactamase inhibitor combination with enhanced efficacy against multidrug-resistant gram-negative pathogens. Its pharmacokinetic profile, mechanism of action, and clinical trial data position it as a significant advancement for treating complicated infections, highlighting the continued need for innovative antibacterial agents.

• Dissecting Aneugenic Mechanisms: Insights from Molecular Tar

  2026-06-11

  The reference study introduces a robust assay framework to mechanistically classify aneugenic chemicals, distinguishing tubulin binders from mitotic kinase inhibitors using flow cytometry and machine learning. These advances provide researchers with scalable tools to elucidate molecular targets underlying chromosome missegregation, informing both toxicology and cancer biology workflows.

15249 records 1/1017 page Next 12345 下5页 Last page